Article Information
History
- February 3, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Iris Leister1,2,§,
- Elisabeth Ponocny-Seliger3,§,
- Herwig Kollaritsch4,*,
- Peter Dungel5,6,
- Barbara Holzer7,
- Johannes Grillari5,6,8,
- Heinz Redl5,6,
- Ivo Ponocny9,
- Claudia Wilfing5,
- Ludwig Aigner1,2,
- Markus Exner10,
- Michaela Stainer5,6,
- Matthias Hackl6,11,
- Thomas Hausner5,6,12,
- Rainer Mittermayr5,6,12 and
- Wolfgang Schaden5,6,13
- 1Institute of Molecular Regenerative Medicine, Paracelsus Medical University, Salzburg, Austria
- 2Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS) and ParaMove, Paracelsus Medical University, Salzburg, Austria
- 3Institute for Quantitative Methods, Sigmund Freud Private University, Vienna, Austria
- 4Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria
- 5Ludwig-Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria
- 6Austrian Cluster for Tissue Regeneration, Vienna, Austria
- 7Austrian Agency for Health and Food Safety, Mödling, Austria
- 8Institute of Molecular Biotechnology, Department of Biotechnology, BOKU – University of Natural Resources and Life Sciences, Vienna, Austria
- 9Department for Applied Statistics and Economics, Modul University Vienna, Vienna, Austria
- 10Labors.at GmbH, Vienna, Austria
- 11TAmiRNA GmbH, Vienna, Austria
- 12AUVA Trauma Center Vienna, Vienna, Austria
- 13AUVA Headquarter, Vienna, Austria
- ↵*corresponding author Correspondence: Univ.-Prof. Dr. Herwig Kollaritsch, e-mail: dr.herwig.kollaritsch{at}gmail.com
Posted February 03, 2021.
Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel
